Inbound Relationships |
Type |
Active |
Source |
Characteristic |
Refinability |
Group |
Product containing precisely balsam of Peru 18 milligram/1 gram and bismuth oxide 21.4 milligram/1 gram and zinc oxide 107.5 milligram/1 gram conventional release cutaneous cream (clinical drug) |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Bismuth oxide (substance) |
Inferred relationship |
Some |
2 |
Product containing precisely balsam of Peru 18 milligram/1 gram and bismuth oxide 21.4 milligram/1 gram and zinc oxide 107.5 milligram/1 gram conventional release cutaneous cream (clinical drug) |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Bismuth oxide (substance) |
Inferred relationship |
Some |
2 |
Balsam of Peru and bismuth oxide and zinc oxide only product in cutaneous dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Bismuth oxide (substance) |
Inferred relationship |
Some |
2 |
Balsam of Peru- and bismuth oxide- and zinc oxide-containing product |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Bismuth oxide (substance) |
Inferred relationship |
Some |
2 |
Product containing balsam of Peru and bismuth oxide and zinc oxide in cutaneous dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Bismuth oxide (substance) |
Inferred relationship |
Some |
2 |
Balsam of Peru and bismuth oxide and zinc oxide only product |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Bismuth oxide (substance) |
Inferred relationship |
Some |
2 |
Bismuth oxide-containing product |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Bismuth oxide (substance) |
Inferred relationship |
Some |
1 |